On October 9th, the members of the Scientific Advisory Board (SAB) got together for a session to discuss EBInnov®’s expertise, achievements, and development prospects. This meeting was a chance to share the research unit’s progress, exchange perspectives, and explore new ideas to support its scientific ambitions.

Three scientific focuses at the heart of the discussions

The talks revolved around the three main focuses that shape EBInnov®’s research activities:

• Bioproduction & bioresources
• Formulation & sensory
• Drug delivery & health

These three areas show the multidisciplinary nature and the complementary expertise within the unit.

An outside perspective to shed light on strategic directions

Through this renewed Council, EBInnov® wants to benefit from an external and strategic perspective to guide its scientific directions, strengthen academic and industrial collaborations, and support the development of multidisciplinary research.

The SAB thus plays a valuable role in the unit’s forward-looking thinking, helping to put its work into perspective with scientific, technological, and industrial challenges.

Thanks to the Council members and the research committee

EBInnov® warmly thanks the members of its SAB for their commitment and contribution to this new momentum:

Fouad Bounouidrate, Jean-Paul Cadoret, Hélène de Clermont-Gallerande, Thibaut Dempton, Lise Dreyfuss, Amandine Goubert, Erwann Guénin, Marc Le Borgne, Didier Lutomski, Stéphane Menio, Damien Seyer, and Catherine Tuleu.

This dynamic is also part of the momentum of the EBInnov® research committee, made up of Clémence Bernard, Delphine Hermouet, Karim Senni, Marc Lavarde, Samar Issa, Rabah Azouani, and Fabrice Ruiz, whom we thank for their involvement.

With this renewed Board, EBInnov® continues its commitment to collaborative research that is connected to the challenges of bioindustries and biotechnologies.